Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 15Neoplasm Metastasis 5Colonic Neoplasms 2Sarcoma 1Rectal Neoplasms 1Neoplasms 1Metastatic Pancreatic Ductal Adenocarcinoma 1Lymphoma, Non-Hodgkin 1Leukemia, Myeloid, Acute 1Leukemia, Lymphocytic, Chronic, B-Cell 1Chondrosarcoma 1Carcinoma, Non-Small-Cell Lung 1Advanced Solid Tumor 1

Interventions

SLC-0111 1IFL protocol 1Gemcitabine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Terminated × Metastatic Pancreatic Ductal Adenocarcinoma × IFL protocol × Clear all
NCT03331640 2022-01-11

PANTHEON

AIO-Studien-gGmbH

Phase 2 Terminated
67 enrolled
Gastrointestinal

Metastatic Pancreatic Ductal Adenocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡